The Effect of Enhanced Recovery After Surgery (ERAS) in Gastric Cancer Surgery

Not Applicable

Active, not recruiting

• Conditions: Anesthesiology; General Surgery

• Registration Number: NCT06209983
• Lead Sponsor: National Taiwan University Hospital

Brief Summary

The investigators aimed to clarify the clinical relevance of the ERAS protocol by evaluating the perioperative course in patients undergoing laparoscopic gastric cancer surgery.

Detailed Description

Gastric cancer is 7th common malignant disease in Taiwan, accounting for 3000 new cases per year. The main treatment of gastric cancer is radical gastrectomy and lymph nodes dissection, which is associated with 13.0\~46 % of surgical morbidities. To minimize the surgical morbidities and enhance patients' recovery, perioperative management is mandatory. Enhanced Recovery After Surgery (ERAS) is a multimodal, multidisciplinary approach to the care of the surgical patient. ERAS process implementation involves a team consisting of surgeons, anesthetists, an ERAS coordinator, and staff from units that care for the surgical patient. The main elements of ERAS include carbohydrate loading before surgery, minimally invasive approaches, balanced management of intravenous fluids, multimodal pain management, early mobilization, and early oral feeding, etc. Some prospective studies have shown its effectiveness in reduce surgical morbidity and hospital stay in colorectal surgery. In Taiwan, there was only limited report to study the use of ERAS in gastric cancer surgery. The investigators would like to integrate these perioperative interventions into the ERAS program, and test its effectiveness in gastric cancer patients undergoing radical gastrectomy at NTUH.

Study Timeline

• Study Start: 2018-12-05
• Status Verified: 2023-10
• Study First Submitted: 2023-10-16
• Study First Submitted QC: 2024-01-14
• Study First Posted: 2024-01-18
• Last Update Submitted: 2024-02-23
• Last Update Posted: 2024-02-28
• Primary Completion: 2027-12-31
• Study Completion: 2027-12-31

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 38

Inclusion Criteria

• Pathological confirmed as gastric adenocarcinoma;
• Gastric cancer patients who will undergo subtotal gastrectomy.

Exclusion Criteria

• Advanced gastric cancer with gastric outlet obstruction;
• Epidural catheter placement contraindicated or inexecutable;
• Have other cancers that have received chemotherapy or radiation therapy;
• Coagulation abnormalities;
• Pregnancy;
• Severe dysfunction of major organs (e.g., heart failure, chronic obstructive pulmonary disease, liver cirrhosis, end-stage renal disease)

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Length of hospital stay	From date of admission until the date of discharge, assessed up to 2 weeks.	When patient discharge.

Secondary Outcome Measures

Name	Time	Method
Complication rates	28 days	The complication rates means if there are any complications occur.

Trial Locations

Locations (1)

National Taiwan University Hospital; 🇨🇳 Taipei, Taiwan